SCHEMBL5400971

SCHEMBL5400971

O=C(Nc1ccc(S(=O)(=O)c2ccc(Cl)cc2)cc1)Oc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
MAPT P10636 4/20 0.57
RAD51 Q06609 2/20 0.56
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
KDM4E B2RXH2 3/20 0.54
THRB P10828 1/20 0.54
GFER P55789 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
GAA P10253 3/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
ATM Q13315 1/20 0.52
TRPV1 Q8NER1 1/20 0.52
PRMT1 Q99873 3/20 0.51
POLB P06746 1/20 0.51
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ENPP3 O14638 1/20 0.49
ENPP1 P22413 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20379647 0.91 ALDH1A1 (0.64) ALDH1A1MAPTRAD51KMT2AMEN1
Phenyl 4-Chlorophenylcarbamate SCHEMBL6258165 0.89 ALDH1A1 (0.70) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL24974648 0.88 ALDH1A1 (0.60) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL20379375 0.88 ABCC9 (0.55) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL20379632 0.87 RAD51 (0.55) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL23431994 0.86 NAMPT (0.52) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL20379864 0.85 NAMPT (0.53) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL20379374 0.84 ALDH1A1 (0.73) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL20381423 0.84 RAD51 (0.55) ALDH1A1MAPTRAD51KMT2AMEN1
SCHEMBL5406539 0.84 SMN1; SMN2 (0.64) ALDH1A1MAPTRAD51KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202269-B2 GlyT2 modulators JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-10 US disclosed
US-20050119245-A1 GlyT2 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2005-06-02 US disclosed
WO-2005044810-A1 GLYT2 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119245-A1 GlyT2 modulators GLRB, GLRA1, GLRA2 ALDH1A1 3023/4885MAPT 450/4885RAD51 4489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.